Study tests new sedative to make colonoscopies more comfortable
NCT ID NCT07161297
Summary
This study aims to find out if a newer sedative drug (remimazolam) works as well as a standard one (midazolam) for colonoscopies in people with inflammatory bowel disease (IBD). Researchers want to see if patients are just as satisfied and if they wake up and recover faster with the newer drug. About 200 adult IBD patients scheduled for a colonoscopy will participate and be randomly assigned to receive one of the two sedation options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IBD - INFLAMMATORY BOWEL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Humanitas Research Hospital
Rozzano, Milano, 20089, Italy
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.